Oklo Inc. announced on June 17, 2025, that its subsidiary, Atomic Alchemy Inc., has commenced site characterization work at a potential location for a commercial radioisotope production facility. This site is located within the Idaho National Laboratory (INL).
This milestone builds on Atomic Alchemy’s prior approvals and agreements, including a Memorandum of Understanding secured in 2020 with the U.S. Department of Energy Idaho Operations Office (DOE-ID). The activities include core borings to collect soil and rock samples, providing essential data on subsurface composition.
The site characterization work aims to ensure the production facility meets stringent safety and building code requirements while supporting the design of a robust structural foundation. This progress is crucial for establishing a reliable domestic supply of essential radioisotopes for healthcare, industry, research, and defense sectors.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.